NF-κB in Mammary Gland Development and Breast Cancer

[1]  Lothar Hennighausen,et al.  Proteotyping of Mammary Tissue from Transgenic and Gene Knockout Mice with Immunohistochemical Markers: a Tool To Define Developmental Lesions , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[2]  D. Green,et al.  The Lymphotoxin-β Receptor Induces Different Patterns of Gene Expression via Two NF-κB Pathways , 2002 .

[3]  M. Merville,et al.  Identification of cytokine-induced nuclear factor-kappaB target genes in ovarian and breast cancer cells. , 2002, Biochemical pharmacology.

[4]  M. Karin,et al.  Missing Pieces in the NF-κB Puzzle , 2002, Cell.

[5]  Michael Karin,et al.  NF-κB in cancer: from innocent bystander to major culprit , 2002, Nature Reviews Cancer.

[6]  H. Nakshatri,et al.  Identification of signal transduction pathways involved in constitutive NF-κB activation in breast cancer cells , 2002, Oncogene.

[7]  Michael Karin,et al.  NF-κB at the crossroads of life and death , 2002, Nature Immunology.

[8]  G. Bren,et al.  RelB Cellular Regulation and Transcriptional Activity Are Regulated by p100* , 2002, The Journal of Biological Chemistry.

[9]  E. Schmidt,et al.  IKKα Provides an Essential Link between RANK Signaling and Cyclin D1 Expression during Mammary Gland Development , 2001, Cell.

[10]  S. Westerheide,et al.  The Putative Oncoprotein Bcl-3 Induces Cyclin D1 To Stimulate G1 Transition , 2001, Molecular and Cellular Biology.

[11]  L. Hennighausen,et al.  Signaling pathways in mammary gland development. , 2001, Developmental cell.

[12]  A. Pardee,et al.  The nuclear factor kappa B (NF-κB): A potential therapeutic target for estrogen receptor negative breast cancers , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Y. Geng,et al.  Specific protection against breast cancers by cyclin D1 ablation , 2001, Nature.

[14]  S. Anderson,et al.  Mammary gland involution is delayed by activated Akt in transgenic mice. , 2001, Molecular endocrinology.

[15]  D. Seldin,et al.  Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer. , 2001, Cancer research.

[16]  F. Kittrell,et al.  Nuclear Factor-κB (NF-κB) Regulates Proliferation and Branching in Mouse Mammary Epithelium , 2001 .

[17]  R. Coffey,et al.  Her-2/neu overexpression induces NF-κB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IκB-α that can be inhibited by the tumor suppressor PTEN , 2001, Oncogene.

[18]  R. Cardiff,et al.  Activation of Akt (Protein Kinase B) in Mammary Epithelium Provides a Critical Cell Survival Signal Required for Tumor Progression , 2001, Molecular and Cellular Biology.

[19]  D. W. Kim,et al.  The RelA NF-κB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells , 2000, Oncogene.

[20]  R. Muraoka,et al.  Dynamic expression and activity of NF-κB during post-natal mammary gland morphogenesis , 2000, Mechanisms of Development.

[21]  D. Lacey,et al.  The Osteoclast Differentiation Factor Osteoprotegerin-Ligand Is Essential for Mammary Gland Development , 2000, Cell.

[22]  Y. E. Chin,et al.  Stat1 as a Component of Tumor Necrosis Factor Alpha Receptor 1-TRADD Signaling Complex To Inhibit NF-κB Activation , 2000, Molecular and Cellular Biology.

[23]  I. Eto.  Molecular cloning and sequence analysis of the promoter region of mouse cyclin D1 gene: implication in phorbol ester‐induced tumour promotion , 2000, Cell proliferation.

[24]  V. Godfrey,et al.  Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. , 2000, Molecular cell.

[25]  W. Doppler,et al.  Activation of NF‐κB p50/p65 is regulated in the developing mammary gland and inhibits STAT5‐mediated β‐casein gene expression , 2000 .

[26]  J. Russo,et al.  Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells. , 2000, Carcinogenesis.

[27]  Richard W. E. Clarkson,et al.  NF-κB Inhibits Apoptosis in Murine Mammary Epithelia* , 2000, The Journal of Biological Chemistry.

[28]  M. Hung,et al.  HER-2/neu Blocks Tumor Necrosis Factor-induced Apoptosis via the Akt/NF-κB Pathway* , 2000, The Journal of Biological Chemistry.

[29]  W. Funkhouser,et al.  Selective activation of NF-κB subunits in human breast cancer: potential roles for NF-κB2/p52 and for Bcl-3 , 2000, Oncogene.

[30]  Hong Zhang,et al.  NF-κB is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesis , 2000, Oncogene.

[31]  H. Pahl.  Activators and target genes of Rel/NF-κB transcription factors , 1999, Oncogene.

[32]  B. Rayet,et al.  Aberrant rel/nfkb genes and activity in human cancer , 1999, Oncogene.

[33]  Yukio Nakamura,et al.  Genetic approaches in mice to understand Rel/NF-κB and IκB function: transgenics and knockouts , 1999, Oncogene.

[34]  David M. Rothwarf,et al.  The NF-κB Activation Pathway: A Paradigm in Information Transfer from Membrane to Nucleus , 1999, Science's STKE.

[35]  L. Pfeffer,et al.  NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase , 1999, Nature.

[36]  J. Romashkova,et al.  NF-κB is a target of AKT in anti-apoptotic PDGF signalling , 1999, Nature.

[37]  Chris Albanese,et al.  NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1 , 1999, Molecular and Cellular Biology.

[38]  M. Arsura,et al.  The inhibitory effects of transforming growth factor beta1 on breast cancer cell proliferation are mediated through regulation of aberrant nuclear factor-kappaB/Rel expression. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[39]  T. Deerinck,et al.  The IKKβ Subunit of IκB Kinase (IKK) is Essential for Nuclear Factor κB Activation and Prevention of Apoptosis , 1999, The Journal of experimental medicine.

[40]  C. Watson,et al.  NF-kappaB and Apoptosis in Mammary Epithelial Cells , 1999, Journal of Mammary Gland Biology and Neoplasia.

[41]  Claus Scheidereit,et al.  NF-κB Function in Growth Control: Regulation of Cyclin D1 Expression and G0/G1-to-S-Phase Transition , 1999, Molecular and Cellular Biology.

[42]  L. Hennighausen,et al.  Think globally, act locally: the making of a mouse mammary gland. , 1998, Genes & development.

[43]  P. Leder,et al.  Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes , 1998, Oncogene.

[44]  A. E. Rogers,et al.  Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. , 1997, The Journal of clinical investigation.

[45]  C. Der,et al.  Oncogenic Ha-Ras-induced Signaling Activates NF-κB Transcriptional Activity, Which Is Required for Cellular Transformation* , 1997, The Journal of Biological Chemistry.

[46]  G. Sledge,et al.  Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth , 1997, Molecular and cellular biology.

[47]  S. Ghosh,et al.  Rel/NF-?B and I?B proteins: an overview , 1997 .

[48]  M. Ip,et al.  Tumor necrosis factor-alpha: a multifunctional regulator of mammary gland development. , 1996, Endocrinology.

[49]  D. White,et al.  Rel/NF-kappaB/IkappaB proteins and cancer. , 1996, Oncogene.

[50]  E M Schwarz,et al.  Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. , 1995, Genes & development.

[51]  V. Castronovo,et al.  Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells. , 1995, Oncogene.

[52]  G. Stamp,et al.  Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. , 1995, Genes & development.

[53]  S. Elledge,et al.  Cyclin D1 provides a link between development and oncogenesis in the retina and breast , 1995, Cell.

[54]  David Baltimore,et al.  Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB , 1995, Nature.

[55]  Emma Lees,et al.  Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice , 1994, Nature.

[56]  J. Penninger,et al.  RANK-L and RANK: T cells, bone loss, and mammalian evolution. , 2002, Annual review of immunology.

[57]  D. Carson,et al.  Synergistic stimulation of MUC1 expression in normal breast epithelia and breast cancer cells by interferon-gamma and tumor necrosis factor-alpha. , 2002, Journal of cellular biochemistry.

[58]  D. Carson,et al.  Synergistic stimulation of MUC1 expression in normal breast epithelia and breast cancer cells by interferon‐γ and tumor necrosis factor‐α , 2002 .

[59]  E. Schmidt,et al.  IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. , 2001, Cell.

[60]  M. Karin,et al.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. , 2000, Annual review of immunology.

[61]  L. Yu-Lee,et al.  Stat5b inhibits NFkappaB-mediated signaling. , 2000, Molecular endocrinology.